Kollodis BioSciences

Kollodis BioSciences is a private biomaterials and life sciences company developing and commercializing recombinant mussel adhesive protein-based products for research, tissue engineering, and medical applications. Its core technology platform, MAPTrix, uses engineered mussel adhesive proteins and bioactive peptide incorporation to create synthetic extracellular matrix coatings, hydrogels, and wet-adhesive products. The company markets research-use products such as MAPTrix ECM coating kits, MAPTrix HyGel 3D hydrogels, adhesive kits, and array products for cell culture and microenvironment engineering. Kollodis also describes preclinical development efforts in wound healing and medical adhesive applications, including chronic wound repair. Overall, the business appears centered on biomaterial platform commercialization rather than a conventional therapeutic drug pipeline.